Tasca Therapeutics

Cambridge, MA · Founded 2022 · Privately Held (backing)

Operator of a biotechnology company intended to develop small molecule drugs for hard-to-treat oncology indications. Tasca Therapeutics is based in Cambridge, MA and was founded in 2022. It was valued at $83.3 million at its early-stage round in Sep 2025, the last priced event on record. It has raised $67 million across 1 recorded round; the latest was a $48.1 million early-stage round in Nov 2024.

PMV mark · valuation
$83.3M
Oct 2026
Priced at
its early-stage round
Sep 2025
Total raised
$67.0M
Last round
Early Stage VC
Nov 2024

Who backs Tasca Therapeutics?

7 investors
InvestorType
8VCVenture capital
The Invus GroupPE / buyout
TIFF Investment ManagementFund of funds
AB Magnitude Ventures Group—
Cure Ventures—
Regeneron Ventures—
Rivas Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Tasca Therapeutics investors

7 investors are on record for Tasca Therapeutics, including 8VC, The Invus Group, TIFF Investment Management and AB Magnitude Ventures Group. The early-stage round in Nov 2024 drew 9 investors.

Free account
More of Tasca Therapeutics with a free account
  • ·Watch Tasca Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Tasca Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View